The Attitudes and Beliefs of Hispanic/Latino Individuals Toward Prescription Opioids and Non-Medical Opioid Use

Opioids Clinical Trial

Official title:

The Attitudes and Beliefs of Hispanic/Latino Individuals Toward Prescription Opioids and Non-Medical Opioid Use

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT05529082
• Other study ID #: 2022-0543
• Secondary ID: NCI-2022-06839
• Status: Not yet recruiting
• Start date: February 28, 2023
• Est. completion date: December 31, 2024

Study information

• Verified date: September 2022
• Source: M.D. Anderson Cancer Center
• Contact: Joseph Arthur, MD
• Phone: (713) 794-1649
• Email: jaarthur[@]mdanderson.org
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

To better understand how people think and feel about prescribed pain medication, including opioids.

Description:

OBJECTIVES:

Primary Objectives:

1. To examine the general attitudes and beliefs of Hispanic/Latino individuals about the use of prescription opioids. The primary outcomes include the responses to questions 13-28 from the Opioid Attitudes and Beliefs survey.

Secondary

1. To evaluate Hispanic/Latino individuals' reports of personal experiences with the use of opioids. The corresponding outcomes are the responses to questions 1-12 from the Opioid Attitudes and Beliefs survey.

2. To find out any potential reasons why some Hispanic/Latino individuals may refuse to use clinically indicated opioid prescriptions. These outcomes are the responses to questions 14-15 from the Opioid Attitudes and Beliefs survey.

3. To explore factors associated with participant's comfort with the use opioid analgesics for their pain. The outcome will be the association between participants' responses to question 2 and their characteristics such as age, gender, race, level of education, extent of acculturation, knowledge of opioids, or previous opioid use.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 200
• Est. completion date: December 31, 2024
• Est. primary completion date: December 31, 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion criteria:

1. Aged 18 years or older.

2. Ability to understand, read, write, or speak English and/or Spanish.

3. Ability to give informed consent.

4. Willingness to participate in the survey.

Exclusion criteria:

1. Refusal to participate in the study

Related Conditions & MeSH terms

• Opioids

Intervention

Other:
• Opioid Attitudes
Participants will complete a questionnaire about your feelings/beliefs on prescription pain medication and your experience with opioids/pain medication. Demographic information about you (such as your age, gender, race, ethnicity, and so on) will also be collected.
• Beliefs survey
Participants will complete a questionnaire about your feelings/beliefs on prescription pain medication and your experience with opioids/pain medication. Demographic information about you (such as your age, gender, race, ethnicity, and so on) will also be collected.

Locations

Country	Name	City	State
United States	M D Anderson Cancer Center	Houston	Texas

Sponsors (3)

Lead Sponsor	Collaborator
M.D. Anderson Cancer Center	National Institutional of Health, UT Health Science Center

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Opioid Attitudes and Beliefs Survey	The survey questionnaire consists of a total of 33 items in five brief sections and responses are mainly based on a 5-point Likert scale ranging from "strongly disagree" to "strongly agree".	through completion of study an average of 1 year

External Links

•   M D Anderson Cancer Center